Actin vs Aurelius Health Group
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Actin
Best for affordable compounded semaglutide with B12 enhancementStarting at $133/mo
Aurelius Health Group
Best for Buyers specifically seeking a transparent, care-inclusive compounded-tirzepatide MICRODOSING program who understand that microdosing has a more limited evidence base and likely smaller weight-loss effect than standard full-dose therapy. Not for buyers wanting maximum-efficacy full-dose GLP-1 treatment. Verify state availability, pharmacy sourcing, and clinical oversight directly.Starting at $89/mo
Side-by-Side Comparison
| Feature | Actin | Aurelius Health Group |
|---|---|---|
| Overall Score | ✓7.0/10 | 6.2/10 |
| Starting Price | $133/mo | ✓$89/mo |
| Editorial Rating | ✓3.5 ★ /5 | 3.1 ★ /5 |
| Features | 2 features | ✓6 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Actin
Pros
- ✓Semaglutide + B12 combination for added energy support
- ✓Transparent pricing — exact cost shown upfront with no hidden fees
- ✓Competitive starting price from $133
Cons
- ✗Semaglutide only — no tirzepatide or liraglutide
- ✗No visible LegitScript or PCAB accreditation
- ✗State availability not disclosed
- ✗Broader platform (hormones, sexual wellness, hair health)
Aurelius Health Group
Pros
- ✓Pricing is fully published and bundled ($89 first month / $199/mo all-in) — more transparent than many compounded-GLP-1 DTC brands
- ✓LegitScript-certified seal displayed
- ✓Care-inclusive model (consults + monthly monitoring + secure messaging) rather than transactional Rx-only
- ✓Unusually candid about the limited evidence base for microdosing
Cons
- ✗MICRODOSE-only model — sub-therapeutic doses have a thinner RCT evidence base than the FDA-approved full-dose tirzepatide regimen (the site acknowledges this); expect smaller weight-loss effect than standard dosing
- ✗No semaglutide / standard full-dose option disclosed
- ✗No named compounding pharmacy partner
- ✗No specific state list and no named medical director / PIC disclosed
- ✗LegitScript ID number not captured at verification (seal present)
Our Verdict
Actin edges out Aurelius Health Group with a higher overall score of 7.0/10 and is particularly strong for affordable compounded semaglutide with B12 enhancement. Aurelius Health Group remains a solid alternative, especially if you're looking for Buyers specifically seeking a transparent, care-inclusive compounded-tirzepatide MICRODOSING program who understand that microdosing has a more limited evidence base and likely smaller weight-loss effect than standard full-dose therapy. Not for buyers wanting maximum-efficacy full-dose GLP-1 treatment. Verify state availability, pharmacy sourcing, and clinical oversight directly..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Actin and Aurelius Health Group head-to-heads in the same category.
- Actin vs CoreAge Rx
- Actin vs TrimRx
- Actin vs Amazon One Medical
- Aurelius Health Group vs NovoCare Pharmacy
- Aurelius Health Group vs Vytora Health
- Aurelius Health Group vs Enhance MD
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.